Literature DB >> 31625222

Pulmonary Embolism and Unfractionated Heparin: Time to End the Roller Coaster Ride.

Aaron W Aday1, Joshua A Beckman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31625222      PMCID： PMC7018537          DOI： 10.1111/acem.13871

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN： 1069-6563            Impact factor:   3.451


× No keyword cloud information.
  12 in total

1.  Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Authors:  Daniel J Quinlan; Andrew McQuillan; John W Eikelboom
Journal:  Ann Intern Med       Date:  2004-02-03       Impact factor: 25.391

2.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

3.  Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: a cohort study in the context of a quality improvement initiative.

Authors:  Benoit Cossette; Marie-Eve Pelletier; Nathalie Carrier; Martin Turgeon; Christian Leclair; Pierre Charron; Donald Echenberg; Tania Fayad; Paul Farand
Journal:  Ann Pharmacother       Date:  2010-05-04       Impact factor: 3.154

4.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Authors:  Stavros V Konstantinides; Guy Meyer; Cecilia Becattini; Héctor Bueno; Geert-Jan Geersing; Veli-Pekka Harjola; Menno V Huisman; Marc Humbert; Catriona Sian Jennings; David Jiménez; Nils Kucher; Irene Marthe Lang; Mareike Lankeit; Roberto Lorusso; Lucia Mazzolai; Nicolas Meneveau; Fionnuala Ní Áinle; Paolo Prandoni; Piotr Pruszczyk; Marc Righini; Adam Torbicki; Eric Van Belle; José Luis Zamorano
Journal:  Eur Respir J       Date:  2019-10-09       Impact factor: 16.671

Review 5.  Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Authors:  Jenneke Leentjens; Mike Peters; Anne C Esselink; Yvo Smulders; Cornelis Kramers
Journal:  Br J Clin Pharmacol       Date:  2017-07-09       Impact factor: 4.335

6.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

7.  Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry).

Authors:  Charles V Pollack; Donald Schreiber; Samuel Z Goldhaber; David Slattery; John Fanikos; Brian J O'Neil; James R Thompson; Brian Hiestand; Beau A Briese; Robert C Pendleton; Chadwick D Miller; Jeffrey A Kline
Journal:  J Am Coll Cardiol       Date:  2011-02-08       Impact factor: 24.094

8.  Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.

Authors:  Silvy Laporte; Patrick Mismetti; Hervé Décousus; Fernando Uresandi; Remedios Otero; Jose Luis Lobo; Manuel Monreal
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

9.  Suboptimal management of unfractionated heparin compared with low-molecular-weight heparin in the management of pulmonary embolism.

Authors:  Y H Khor; R Smith; C F McDonald
Journal:  Intern Med J       Date:  2014-04       Impact factor: 2.048

10.  Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.

Authors:  Jay Giri; Akhilesh K Sista; Ido Weinberg; Clive Kearon; Dharam J Kumbhani; Nimesh D Desai; Gregory Piazza; Mark T Gladwin; Saurav Chatterjee; Taisei Kobayashi; Christopher Kabrhel; Geoffrey D Barnes
Journal:  Circulation       Date:  2019-10-04       Impact factor: 29.690
View more
  1 in total

1.  The Open Vein Hypothesis and Postthrombotic Syndrome: Not Dead Yet.

Authors:  Aaron W Aday; Joshua A Beckman
Journal:  Circulation       Date:  2021-03-22       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.